Rare Variant and Epigenomic Analysis in ME/CFS
Duration: 36 months, Funding volume: € 999,169
Decoding GNB1E: Advanced Drug Repurposing for Personalized Treatment
Duration: 48 months, Funding volume: € 999,979
Systems precision medicine of inborn errors of the immune system (PrecisePID)
Duration: 48 months, Funding volume: € 923,200
Network Medicine - An interactome-based approach to rare diseases
Duration: 96 months, Funding volume: € 1,598,300